These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7368430)

  • 1. [Urinary fibrinolytis activity and the blood coagulation system in chronic pyelonephritis].
    Khvan PT
    Urol Nefrol (Mosk); 1980; (1):10-3. PubMed ID: 7368430
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood coagulation and excretion of factors of coagulation and fibrinolysis with urine in patients with pyelonephritis].
    Zorina SS
    Klin Med (Mosk); 1975 Mar; 53(3):48-52. PubMed ID: 1117683
    [No Abstract]   [Full Text] [Related]  

  • 3. [Indices of fibrinolysis and hemostasis in chronic pyelonephritis].
    Andreenko GV; Panchenko VM; Podorol'skaia LV
    Lab Delo; 1977; (3):139-43. PubMed ID: 67260
    [No Abstract]   [Full Text] [Related]  

  • 4. [Kidneys as an effector in the regulation of blood clotting].
    Sokratov NV; Skipetrov VP
    Usp Fiziol Nauk; 1981; 12(1):80-96. PubMed ID: 7013321
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
    Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
    Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urinary urokinase and blood fibrinolytic activity in patients with nephrolithiasis and other urinary tract diseases].
    Kotschy M; Lorenz T; Kaniak J; Janukowicz-Lorenz H; Lorenz J; Dabrowska B
    Pol Tyg Lek; 1975 Oct; 30(43):1773-7. PubMed ID: 52868
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood urokinase plasminogen activator system in chronic urticaria.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Arch Dermatol Res; 2007 Jan; 298(8):409-11. PubMed ID: 17102952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary fibrinolytic enzyme activity in systemic diseases and chronic glomerulonephritis].
    Palienko IA; Belitskaia GA
    Vrach Delo; 1988 Feb; (2):71-3. PubMed ID: 3381527
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinolysis system in patients with bronchial asthma.
    Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
    Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic viral hepatitis C, oxidative stress and the coagulation/fibrinolysis system in haemodialysis patients.
    Pawlak K; Zolbach K; Borawski J; Mysliwiec M; Kovalchuk O; Chyczewski L; Pawlak D
    Thromb Res; 2008; 123(1):166-70. PubMed ID: 18452978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indicators of blood coagulation and fibrinolytic activity of the urine in children with calculous pyelonephritis].
    Kanatbaeva AB; Mazhitova RT; Mustafina SM
    Pediatriia; 1989; (5):22-6. PubMed ID: 2771569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [State of the blood coagulation system in chronic pyelonephritis].
    Zakariadze TV; Kandelaki KI; Meskhi LSh; Morchiladze AM; Chachua ZM
    Urol Nefrol (Mosk); 1978; (6):13-7. PubMed ID: 715951
    [No Abstract]   [Full Text] [Related]  

  • 15. [Urokinase excretion and fibrinolysis in infectious kidney diseases].
    Bachmann HJ; Tacke E; Haupt H
    Monatsschr Kinderheilkd (1902); 1974 Jul; 122(7):567-8. PubMed ID: 4411414
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fibrinolysis in children with inflammatory diseases of kidneys and urinary tract].
    Bachmann HJ; Haupt H
    Z Kinderheilkd; 1971; 109(4):300-6. PubMed ID: 5555169
    [No Abstract]   [Full Text] [Related]  

  • 17. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Status of the coagulation and fibrinolytic systems of the blood in patients with chronic pyelonephritis].
    Rybas EP
    Urol Nefrol (Mosk); 1988; (1):70-4. PubMed ID: 3284141
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B.
    Zhou H; Wu X; Lu X; Chen G; Ye X; Huang J
    Thromb Res; 2009; 123(3):537-42. PubMed ID: 18691743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.